NEW YORK (GenomeWeb News) — A California private equity group plans to invest as much as $700 million in new health-care initiatives that will include funding for predictive genomics, as well as other high-tech health-care programs such as telemedicine and chronic care improvement, the fund, Health Evolution Partners, said today.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.